Jonathan Chappell, Evercore ISI Senior Managing Director, joins 'Closing Bell: Overtime' to discuss FedEx earnings, company ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $307.2, a high ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 12.56% ...

Tax-loss selling candidates such as Nike, could surprise investors with big gains in 2025, say Evercore strategists.

Evercore ISI analyst Gavin Clark-Gartner maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) on December 20 and set a ...

Keefe Bruyette upgraded Evercore (EVR) to Outperform from Market Perform with a price target of $339, up from $269. The firm says that despite ...

Fintel reports that on December 20, 2024, Keefe, Bruyette & Woods upgraded their outlook for Evercore (NYSE:EVR) from Market ...

It's been a bit of an odd year for Evercore Heroes: Ascension. To catch you up, the game entered 2024 as kind of a mash-up ...

We recently published a list of 10 Buzzing AI Stocks on Latest News and Ratings. In this article, we are going to take a look at where Oracle Corporation (NYSE:ORCL)) stands against other buzzing ...

Cabaletta Bio Inc (CABA) stock saw a decline, ending the day at $2.36 which represents a decrease of $-0.02 or -0.84% from the prior close of $2.38. The stock opened at $2.4 and touched a low of $2.25 ...

Across the recent three months, 5 analysts have shared their insights on Evercore (NYSE:EVR), expressing a variety of opinions spanning from bullish to bearish. The table below offers a condensed ...

BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its target price lifted by Evercore ISI from $45.00 to $50.00 in a research note issued to investors on Monday,Benzinga reports.The firm ...